Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Reserach and Development

Femme et Homme Max 99 ans
Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Reserach and Development MAJ Il y a 4 ans

A 6-MONTH, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, SAFETY, TOLERABILITY, AND EFFICACY STUDY OF 3 DOSES OF LECOZOTAN SRA-333 SR IN OUTPATIENTS WITH MILD TO MODERATE ALZHEIMER S DISEASE TREATED WITH A CHOLINESTERASE INHIBITOR The primary objective is to determine the safety, tolerability, and efficacy of three doses of lecozotan SR 2, 5, 10 mg in combination with a cholinesterase inhibitor in patients with mild to modera...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations